Epirubicin in a breast cancer patient with Gilbert's syndrome: apparent lack of major pharmacokinetic alterations.
Riggi
M
M
Poggesi
I
I
Regazzi
M B
MB
Grasso
S
S
Fittipaldo
A
A
Seematter
R J
RJ
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D005500:Follow-Up Studies; D005878:Gilbert Disease / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin